By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website –
Check out our openings –

Key Statistics

Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN


Sanofi US 


Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 

Company News
Regeneron (REGN) And Sanofi (SNY) Announce Positive Study Results For DUPIXENT (Dupilumab) In Patients With Moderate-To-Severe Atopic Dermatitis 9/18/2017 7:29:54 AM
Regeneron (REGN)'s Delivery Isn't Matching The Hype 9/14/2017 6:31:48 AM
This Regeneron (REGN) Drug Just Took Another Step Toward Blockbuster Status 9/13/2017 5:52:06 AM
5 Things Regeneron (REGN)'s CEO Said As The Biotech Stock Sank 9/12/2017 6:41:05 AM
Regeneron (REGN) And Sanofi (SNY) Announce Positive Dupilumab Topline Results From Phase III Trial In Uncontrolled Persistent Asthma 9/11/2017 8:34:22 AM
FDA Calls Regeneron (REGN), Sanofi (SNY) Carcinoma Drug a Breakthrough 9/8/2017 5:33:45 AM
Regeneron (REGN) And Sanofi (SNY) To Present New Analyses From Praluent (Alirocumab) Injection Trials At The ESC Congress 2017 8/28/2017 6:09:18 AM
This Drug Could be the Most Crucial in Regeneron (REGN)'s Massive Pipeline 8/23/2017 6:13:24 AM
Uptake Of Sanofi (SNY)/Regeneron (REGN)'s Dupixent For Atopic Dermatitis Strong, But Sales Representative Contact Rates Leave Something To Be Desired 8/22/2017 6:21:05 AM
Could Regeneron (REGN) Be The Best Biotech Stock To Buy? 8/18/2017 6:18:57 AM